AYTU BIOPHARMA INC
AYTU · NASDAQ
更新於 2026-10-14 09:27:48
$1.99+1.01%
- 今日最高
- $2.03
- 今日最低
- $1.95
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $1.99
- 昨天收盤價
- $1.97
- 成交量
- 23.24K
- 市值
- $21.4M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-1.48
昨天價格區間
$1.96$2.04
52週價格區間
$1.80$3.06
公司概況
- 板塊
- 醫療保健
- 行業
- 製藥
- 子行業
- 藥品製造商 - 專科及仿製藥
- 總部
- 7900 EAST UNION AVENUE, DENVER, CO, UNITED STATES, 80237
- 國家
- 美國
- 上市日期
- 2017-10-20
- 財年截止
- 六月
- 流通股數
- 10.73M
- CIK
- 0001385818
- 官方網址
- aytubio.com
Aytu Biopharma, Inc. 是一家專科製藥公司，在美國及國際市場專注於開發及營銷治療性腺功能減退症（睪固酮水平偏低）、咳嗽及上呼吸道症狀、失眠以及男性不育症的新型產品。公司總部位於科羅拉多州恩格爾伍德。
財務指標
營業收入
2026-06-30
$16.1M
2026-03-31
$12.41M
2025-12-31
$15.16M
2025-09-30
$13.88M
營業支出
2026-06-30
$12.47M
2026-03-31
$10.9M
2025-12-31
$11.06M
2025-09-30
$10.69M
淨利潤
2026-06-30
-$15K
2026-03-31
-$5.61M
2025-12-31
-$10.58M
2025-09-30
$1.96M
淨利潤率
2026-06-30
-0.09%
2026-03-31
-45.26%
2025-12-31
-69.79%
2025-09-30
14.14%
每股收益
2026-06-30
$-0.05
2026-03-31
$-0.41
2025-12-31
$-0.23
2025-09-30
$-0.09
息稅折舊攤銷前利潤
2026-06-30
$1.42M
2026-03-31
-$4.05M
2025-12-31
-$9.13M
2025-09-30
$3.28M
有效稅率
2026-06-30
275%
2026-03-31
-0.17%
2025-12-31
--
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $16.1M | $12.41M | $15.16M | $13.88M |
| 營業支出 | $12.47M | $10.9M | $11.06M | $10.69M |
| 淨利潤 | -$15K | -$5.61M | -$10.58M | $1.96M |
| 淨利潤率 | -0.09% | -45.26% | -69.79% | 14.14% |
| 每股收益 | $-0.05 | $-0.41 | $-0.23 | $-0.09 |
| 息稅折舊攤銷前利潤 | $1.42M | -$4.05M | -$9.13M | $3.28M |
| 有效稅率 | 275% | -0.17% | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。